Uterine and ovarian agenesia. an unusual combination causing hypogonadism HYPERGONADOTROP (HH)
DOI:
https://doi.org/10.18041/2390-0512/biociencias.1.7845Keywords:
Gonadal dysgenesis, hypergonadotropic hypogonadism, puberty, primary amenorrheaAbstract
Introduction: Hypergonadotropic Hypogonadism (HH) is the cause of delayed puberty, characterized by an intrinsic gonadal condition that interrupts the action of the hypothalamic-pituitary-gonadal axis. With a varied etiology, including genetic or acquired alterations. The association of uterine and ovarian agenesis in the same patient as the cause of HH is unusual. There are cases described in the HH literature with agenesis, dysgenesis, ovarian hypoplasia, but without uterine alteration. Case description: 12-year-old patient who consults for short stature with absence of pubertal development. Hormonal studies suffering from HH. Pelvic ultrasound and pelvic magnetic resonance imaging are requested, confirming gonadal and uterine agenesis. Management is performed with calcium supplements, estrogens as hormonal replacement to induce secondary sexual characteristics and support in your bone health. Achieve a normal final size according to your average parental size and improvement in your quality of life. Discussion: Short stature and absence of secondary sexual characteristics is a form of clinical presentation of HH. Ovarian agenesis as a cause of HH, associated with uterine agenesis in the same patient, is an unusual association, motivating the publication of the case. Conclusion: It is important to recognize HH early, in order to provide timely treatment, and thus improve quality of life.
Downloads
References
Ramón Cañete Estrada, Mercedes Gil Campos M. DCV. Pubertad retrasada. Hipogonadismos. AEP. 2019;(1):253–66.
Güemes-Hidalgo M, Ceñal González-Fierro M, Hidalgo Vicario M. Pubertad y adolescencia. Adolescere Rev Form Contin la Soc Española Med la Adolesc. 2017;5(1):7–22.
Bhagavath B, Greiner E, Griffiths KM, Winter T, Alur-Gupta S, Richardson C, et al. Uterine Malformations: An Update of Diagnosis, Management, and Outcomes. Obstet Gynecol Surv. 2017;72(6):377–92.
Porcu G, Heckenroth H. Malformaciones uterinas e infertilidad. EMC - Ginecol [Internet]. 2005;41(3):1–11. Available from: http://dx.doi.org/10.1016/S1283-081X(05)44252-6
Howard SR, Dunkel L. Delayed Puberty—Phenotypic Diversity, Molecular Genetic Mechanisms, and Recent Discoveries. Endocr Rev. 2019;40(5):1285–317.
Shaco-levy R, Robboy SJ. 23 - Normal Ovaries, Inflammatory and Non-Neoplastic Conditions [Internet]. Third Edition. Pathology of the Female Reproductive Tract. 2018. 509–534 p. Available from: http://dx.doi.org/10.1016/B978-0-7020-4497-7.00023-6
de Marqui ABT. Turner syndrome and genetic polymorphism: a systematic review. Rev Paul Pediatr (English Ed [Internet]. 2015;33(3):363–70. Available from: http://dx.doi.org/10.1016/j.rppede.2015.06.001
Álvarez-Nava F, Lanes R. Epigenetics in Turner syndrome. Clin Epigenetics. 2018;10(1):1–20.
Smith J, Moyle P, Addley H, Freeman S. Imaging benign gynaecological conditions. Obstet Gynaecol Reprod Med [Internet]. 2018;28(8):229–36. Available from: https://doi.org/10.1016/j.ogrm.2018.07.003
Horii M, Boyd TK, Quade BJ, Crum CP, Parast MM. Chapter 1 - Female Genital Tract Development and Disorders of Childhood [Internet]. Third Edition. Diagnostic Gynecologic and Obstetric Pathology. Elsevier Inc.; 2018. 1–21 p. Available from: https://doi.org/10.1016/B978-0-323-44732-4.00001-7
CARTA CLÍNICA Síndrome de Mayer-Rokitansky- Küster-Hauser : a propósito de un caso Mayer-Rokitansky-Küster-Hauser syndrome : A case report Discusión. 2016;42(5):50–2.
Ortiz FM, Mendoza CM, Lugo IB, Rodríguez BC, Soto JOC. Síndrome de ovario resistente. Reporte de un caso. Ginecol Obstet Mex. 2011;79(7):436–40.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Biociencias

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
-
Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
-
NoComercial — No puede utilizar el material para una finalidad comercial.
-
CompartirIgual — Si remezcla, transforma o crea a partir del material, deberá difundir sus contribuciones bajo la misma licencia que el original.
- No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.